维普中文期刊产品整合服务
177篇 您的检索式:作者名="SYRIGOS K"
    题名 作者 年代 出处 被引量
1A multieenter phase II tri- al of docetaxel and eapeeitabine as salvage treatment in anthracyeline- and taxane-pretreated patients with metastatic breast cancer 显示文摘Karaehaliou N Ziras N Syrigos K 2012Cancer Chemother Pharmaeol2012,70,1:1
2Bisphospho- nates:Prevention of bone metastases in lung cancer 显示文摘Decoster L de Marinis F Syrigos K 2012Recent Results Cancer Res2012,192,:1
3Serum levels of tumor necrosis factor-alpha and nutritional status in pancreatic cancer patients显示文摘Karayiannakis A J Syrigos K N Polychronidis A 2001Anticancer Res2001,21,2:1
4Bisphosphonates : prevention of bone metastases in lung cancer 显示文摘Decoster L de Marinis F Syrigos K 2012Recent Results Cancer Res2012,192,:1
5The prognostic significance of autoantibodies againet dsDNA in patient with colcrectal adenocarcinoma显示文摘Syrigos KN Charalambopoulos A Pliarchopou K 2000Anticancer Res2000,2020,:1
6A muhicenter phase Ⅲ trial comparing irinotecan-gemcitabine (IG) with gemcitabine (G) monotherapy as first-line treatment in patients with locally advanced or metastatic pancreatic cancer 显示文摘Stathopoulos G P Syrigos K Aravantinos G 2006Br J Cancer2006,95,5:1
7Developments in the treatment of non-small cell lung cancer显示文摘GKIOZOS I CHARPIDOU A SYRIGOS K 0,,04:1
8Gemcitabine versus gemcitabine-carboplatin for patients with advanced nonsmall cell lung cancer and a performance status of 2:a prospective randomized phase Ⅱ study of the Hellenic Cooperative Oncology Group显示文摘Kosmidis PA Dimopoules MA Syrigos K 2007Thorac Oncol2007,2,2:1
9Serum levels of E-selectin, ICAM-1 and VCAM-1 in colorectal cancer patients: correlations with clinicopathological features, patient survival and tumour surgery 显示文摘Alexiou D Karayiannakis A J Syrigos K N 2001Eur J Cancer2001,37,18:1
10Bisphosphonates:prevention of bone metastases in lung cancer显示文摘Decoster L de Marinis F Syrigos K 2012Recent Results Cancer Res2012,192,:1
11Gemcitabine versus gemeitabine-earboplatin for patients with advanced non-small cell lung cancer and a performance status of 2 : a prospective randomized phase Ⅱ study of the Hellenic Cooperative Oncology Group 显示文摘Kosmidis PA Dimopoulos MA Syrigos K 2007J Thorae Oncol2007,2,2:1
12Risph0sphonates:Prevention of bone metastases in lung cancer显示文摘Decoster L deMarinis F Syrigos K et a1 2012Rec Results Cancer Res2012,192,:1
13FOLFOXIRI (folinic acid,5-fluorouracil,oxaliplatin and irinotecan) vs FOLFIRI (folinic acid,5-fluorouracil and irinotecan) as first-line treatment in metastatic colorectal cancer (MCC):a multicentre randomised phase Ⅲ trial from the Hellenic Oncology Research Group (HORG)显示文摘Souglakos J Androulakis N Syrigos K 2006Br J Cancer2006,94,:1
14A phase Ⅰ -Ⅱstudy of biweekly gemcitabine and irinotecan as second-line chemotherapy in non-small cell lung cancer after prior taxane + platinum-based regimens 显示文摘Kosmas C Tsavaris N Syrigos K 2007Cancer Chemother Pharmacol2007,59,1:1
15The role of E-cadherin-catenin complex:more than an intercellular glue?显示文摘Harrington K J Syrigos K N 2000Ann Surg Oncol2000,7,10:1
16Genetic aheratious in pancreatic cancer显示文摘Saif MW Karapanagiotou L Syrigos K 2007World J Gastroenterol2007,13,33:1
17Developments in the treatment of non-small cell lung cancer显示文摘GKIOZOS I CHARPIDOU A SYRIGOS K 2007Anticancer Res2007,27,4:1
18FOLFOXIRI(folinic acid,5-fluorouracil,oxaliplatin and irinotecan) VS FOLFIRI (foiinic acid,5-fluorouracil and irinotecan) as first-line treatment in metastatic colorectal cancer (MCC):a multicentre andomised phase Ⅲtrial from the Hellenic Oncology Research Group (HORG)显示文摘Souglakos J Androulakis N Syrigos K 2006Br J Cancer2006,94,6:1
19Clinical significance of serum levels of E-selectin, intercellular adhesion molecule-1, and vascular cell adhesion molecule-1 in gastric cancer patients显示文摘Alexiou D Karayiannakis A J Syrigos K N 2003Am J Gastroenterol2003,98,2:1
20Pancreatic cancer:updates on translational research and future applications显示文摘Sarris E G Syrigos K N Saif M W 2013Journal of the pancreas2013,14,2:1
返回顶部 每页显示:
共9页 首页 上一页 第1页 下一页 末页 /9 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费